欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/5577/002
药品名称Lanthan Mylan 750 mg Kautabletten
活性成分
    • lanthanum(III)carbonate 1605.03 mg
剂型Chewable tablet
上市许可持有人Mylan Germany GmbH Lütticher Straße 5 53842 Troisdorf Deutschland
参考成员国 - 产品名称Germany (DE)
Lanthan Mylan 750 mg Kautabletten
互认成员国 - 产品名称
    • France (FR)
    • Sweden (SE)
    • Latvia (LV)
      Calafos 750 mg košļājamās tabletes
    • Lithuania (LT)
      Calafos 750 mg kramtomosios tabletės
    • Estonia (EE)
      CALAFOS
    • Malta (MT)
      Lanthanum carbonate 750 mg Chewable Tablets
    • Croatia (HR)
    • United Kingdom (Northern Ireland) (XI)
    • Norway (NO)
    • Denmark (DK)
    • Netherlands (NL)
许可日期2020/12/02
最近更新日期2024/08/07
药物ATC编码
    • V03AE03 lanthanum carbonate
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase